zafirlukast  - Drug Details
📊 Estimates zafirlukast  Dialyzability By Different_Modalities

zafirlukast 

Complete Drug Information

Drug Name
zafirlukast 
Trade Names
Accolate
Pregnancy Category
AU: B1
Bioavailability
Unknown
Routes of Administration
Oral
Protein Binding
>99% (albumin)%
Metabolism
Hepatic (CYP2C9-mediated)
Elimination
10 hours
Excretion
Fecal
Formula
C31H33N3O6S
Molar Mass
575.68
Melting Point
138 to 140 °C
Volume of Distribution
70 L/kg

🤰 Pregnancy Category Information

Category: AU: B1

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have not shown evidence of an increased occurrence of fetal damage.